[Optimized extracorporeal shockwave lithotripsy of gallbladder calculi: a prospective randomized therapy comparison]

Z Gastroenterol. 1999 Mar;37(3):209-17.
[Article in German]

Abstract

Is "pulverization" or "fragmentation" the best endpoint of extracorporeal shock wave application in ESWL of gallbladder stones? Has gallbladder motility a potential for the prevention of stone recurrence?

Methods: Prospective, monocentric study with randomization between the conventional treatment strategy (endpoint of shock wave application: fragments < or = 4 mm, concomitant oral chemolitholysis) and an intensified treatment strategy (endpoint of shock wave application: Pulverization, no chemolitholysis). Prevention of stone recurrence: At least once per month for one hour after a meal standardized position (back position, lowered chest).

Results: 34 patients, age 46 +/- 14 years (27 women, seven men) were included (F-ESWL: n = 18; P-ESWL: n = 16). Gallbladder motility, number, size and CT-measured calcifications of stones were comparable for both groups. P-ESWL patients received more shock wave pulses than F-ESWL patients and more treatment sessions. P-ESWL resulted in a better fragmentation and pulverization of stones was reached significantly more often (p < 0.05). The time period for stone clearance was significantly depending on the fragmentation result (pulverization: 0.7 months vs. fragments < or = 4 mm: 6.6 months vs. fragments > or = 4 mm: 8.0 months; p < 0.01). The stone free rate after twelve months was 87.5% for P-ESWL and 72.2% for F-ESWL (n.s.) and correlated significantly with the fragmentation result (p < 0.01). Pain sensations during stone clearance were significantly reduced by P-ESWL. Stonefree patients were followed up for 30 +/- 13 months, the total recurrence rate was 7.1%.

Conclusions: Aiming for pulverization of gallbladder stones by means of intensified extracorporeal shock wave application is at least equal or in tendency superior compared to disintegration to fragements < or = 4 mm. Gallbladder motility might be useful to prevent gallstone recurrence after successful ESWL.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Chenodeoxycholic Acid / administration & dosage
  • Cholelithiasis / diagnostic imaging
  • Cholelithiasis / therapy*
  • Combined Modality Therapy
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Gallbladder Emptying / physiology
  • Humans
  • Lithotripsy / methods*
  • Male
  • Middle Aged
  • Pain Measurement
  • Premedication
  • Prospective Studies
  • Recurrence
  • Treatment Outcome
  • Ultrasonography
  • Ursodeoxycholic Acid / administration & dosage

Substances

  • Drug Combinations
  • Chenodeoxycholic Acid
  • Ursodeoxycholic Acid